Project Grant HT94252410163
Award Date 9/1/24
Completion Date 8/31/28
Dollars Obligated $3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Francisco, CA, USA
Similar Awards
- The Defense Health Agency awarded a $311,000 Project Grant to the University of Washington under the Military Medical Research and Development federal grant program (CFDA 12.420) to manage mitochondrial disorders through increased intestinal fermentation and reduced metabolic burden from January 1, 2023 to December 31, 2024. The University of Washington will deliver research to transform health care for service members and the public by investigating medical solutions for the battlefield through...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The Defense Health Agency awarded a $1,397,266 project grant to The University of Queensland under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2023 through February 28, 2026 to develop peptide inhibitors targeting sodium channels for the treatment of Amyotrophic Lateral Sclerosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- The Defense Health Agency awarded a $659,922 Project Grant to Macquarie University in Australia under the Military Medical Research and Development program (CFDA 12.420). The grant funds a gene therapy research project aimed at developing a treatment for delaying the onset of Amyotrophic Lateral Sclerosis (ALS) through nuclear TDP-43 supplementation. The research will be conducted at Macquarie University over a 2-year period from September 2025 to September 2027. This project grant is part of...
- The Defense Health Agency awarded a $390,000 Project Grant to the Sanford Burnham Prebys Medical Discovery Institute to support research using systems genetics to probe for gene interactions in congenital heart disease. The two-year award, made under the Military Medical Research and Development program (CFDA 12.420), will fund work from February 2021 through August 2023. The Military Medical Research and Development program aims to transform military and public health through innovative...
- This Project Grant from the Defense Health Agency provides $734,781 to Formation Venture Engineering Foundry Inc. for precision medicine immunotherapy research under the Military Medical Research and Development program (CFDA 12.420). The research aims to develop medical solutions for treating neurodegeneration in amyotrophic lateral sclerosis patients who test positive for human endogenous retrovirus K. The awardee will conduct applied and advanced biomedical research from June 2023 through...
- This $1,644,309 Project Grant was awarded on February 1, 2025 by the Defense Health Agency, which administers the Military Medical Research and Development program (CFDA 12.420), to The General Hospital Corporation (doing business as Massachusetts General Hospital) in Boston, MA. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the research will focus on functional molecular networks...
- The Department of Defense's Defense Health Agency awarded a $921,600 Project Grant to The General Hospital Corporation (Massachusetts General Hospital) to research the "Therapeutic Effects of Sulfide Catabolism and Novel Trisulfide Compounds for Amyotrophic Lateral Sclerosis." The grant, under the Military Medical Research and Development program (CFDA 12.420), supports foundational biomedical research aimed at developing novel treatments for amyotrophic lateral sclerosis (ALS)....
- Federal Grant Award Summary Massachusetts General Hospital (MGH) received a $165,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025 through August 31, 2027. The award supports research mapping drug-sensitive gene expression profiles to spatial patterns of heterogeneity in a mouse model of schwannoma. This research initiative advances the Defense Health Agency's mission to transform healthcare...
- The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...